Finepoint Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,605,800
Closed -$16M 9
2015
Q2
$16M Hold
1,605,800
4.65% 7
2015
Q1
$20.4M Buy
+1,605,800
New +$20.4M 6.86% 5